Assignee
HASUMI KENICHIRO
JP·8 granted patents·5 pending applications·15 citations·filing 2005–2023
Top patents by PatentIndex Score
13 records- 0182US11020468B2Compositions, methods and therapies for administering antigen peptideHASUMI KENICHIRO·Filed 2019·Granted Jun 1, 2021·1 cites·6 claims
- 0280US10278992B2Therapy and methods for introducing immature and dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treatment of tumorsHASUMI KENICHIRO·Filed 2018·Granted May 7, 2019·1 cites·20 claims
- 0380US9089593B2Dendritic cell tumor injection (DCTI) therapyHASUMI KENICHIRO·Filed 2011·Granted Jul 28, 2015·2 cites·5 claims
- 0479US8784830B2Antigen peptide and use thereofHASUMI KENICHIRO·Filed 2011·Granted Jul 22, 2014·4 cites·12 claims
- 0574US10426825B2Compositions, methods and therapies for administering antigen peptideHASUMI KENICHIRO·Filed 2018·Granted Oct 1, 2019·1 cites·6 claims
- 0674US8088397B2Human lymphocyte vaccine adjuvantHASUMI KENICHIRO·Filed 2010·Granted Jan 3, 2012·5 cites·12 claims
- 0770US8075882B2Adoptive immune cells for tumor vaccinesHASUMI KENICHIRO·Filed 2009·Granted Dec 13, 2011·1 cites·4 claims
- 0869US8076132B2Dendritic cell tumor injection (DCTI) therapyHASUMI KENICHIRO·Filed 2008·Granted Dec 13, 2011·0 cites·16 claims
- 0966US2026085286A1Anti-tumor immune response enhancerHASUMI KENICHIRO·Filed 2023·Application pending·0 cites
- 1059US2025000905A1Composition for treating solid malignant tumor, and kit for treating solid malignant tumorHASUMI KENICHIRO·Filed 2022·Application pending·0 cites
- 1157US2008160050A1Dendritic cell tumor injection therapy and related vaccineHASUMI KENICHIRO·Filed 2007·Application pending·0 cites
- 1250US2006216269A1Dendritic cell tumor injection (DCTI) therapyHASUMI KENICHIRO·Filed 2005·Application pending·0 cites
- 1350US2020030375A1Therapy and methods of introducing immature dendritic cells and/or cytoxic t lymphocyte and anti pd-1 / pd-l1 antibody for treatment of tumorsHASUMI KENICHIRO·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →